
8.34 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 6.51 Today|||52-Week Range 14.34 | +11.05% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $482.9M |
Evolus, Inc. 520 Newport Center Drive Newport Beach California 92660 |
David Moatazedi | President, Chief Executive Officer & Director |
Sandra Beaver | Chief Financial Officer |
Rui Avelar | Chief Medical Officer, Head-Research & Development |
Dan Stewart | Vice President & General Manager |
Christos Monovoukas | Senior Vice President-Corporate Development |